Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational study

Aims Adverse drug reactions (ADRs) contribute to poorer patient outcomes and additional burden to the healthcare system. However, data on the true burden, relevant types and drugs causing ADRs are lacking. The aim of this study was to determine the prevalence of ADR‐related hospitalization in the general adult population in Singapore and to investigate their characteristics. Methods We prospectively recruited 1000 adult patients with unplanned admission to a large tertiary‐care hospital. Two independent reviewers evaluated all suspected ADRs for causality, type, severity and avoidability. The prevalence of ADR‐related hospitalization was calculated based on ‘definite’ and ‘probable’ ADRs. Logistic regression was used to evaluate predictors for having an ADR at admission. Results The prevalence of all ADRs at admission was 12.4% (95% CI: 10.5–14.6%) and ADRs causing admission was 8.1% (95% CI: 6.5–10.0%). The most common ADRs were gastrointestinal‐related. The most common drug category causing ADRs were cardiovascular drugs. Patients with ADRs had a longer length of stay than those who did not (median 4 vs. 3 days, P = 1.70 × 10−3). About 30% of ADRs at admission were caused by at least one drug with a clinical annotation in the Pharmacogenomics KnowledgeBase (PharmGKB), suggesting that some of these ADRs may have been predicted by pharmacogenetic testing. Conclusions We have quantified the burden and characteristics of clinically impactful ADRs in the Singaporean general adult population. Our results will provide vital information for efforts in reducing ADRs through targeted vigilance, patient education and pharmacogenomics in Singapore.

• Publication year

  2016

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2016-09-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/bcp.13081PMID 27640819PMCID 5099543
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adverse Drug Reactions

  2019cited by this paper
• Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational study

  2016cited by this paper
• Adverse drug reactions experience in a teaching hospital in Jordan

  2015cited by this paper
• Adverse drug reactions as a cause of admission to a Dublin-based university teaching hospital

  2015cited by this paper
• Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study

  2015cited by this paper
• The Incidence, Nature and Consequences of Adverse Events in Iranian Hospitals.

  2015cited by this paper
• Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials

  2015cited by this paper
• Understanding genetic variation - the value of systems biology.

  2014cited by this paper
• Characteristics of unplanned hospital admissions due to drug-related problems in cancer patients

  2014cited by this paper
• Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission

  2014cited by this paper
• Building pharmacogenetics into a pharmacovigilance program in Singapore: using serious skin rash as a pilot study

  2014cited by this paper
• Diagnostic accuracy of HLA-B*57:01 screening for the prediction of abacavir hypersensitivity and clinical utility of the test: a meta-analytic review.

  2014cited by this paper
• R: A language and environment for statistical computing.

  2014cited by this paper
• Mechanisms of Adverse Drug Reactions

  2014cited by this paper
• Determining the frequency and preventability of adverse drug reaction-related admissions to an Irish University Hospital: a cross-sectional study

  2013cited by this paper
• Clinical and economic burden of adverse drug reactions

  2013cited by this paper
• Pharmacogenomics Knowledge for Personalized Medicine

  2012cited by this paper
• Optimizing Drug Outcomes Through Pharmacogenetics: A Case for Preemptive Genotyping

  2012cited by this paper
• Prevalence of Unplanned Hospitalizations Caused by Adverse Drug Reactions in Older Veterans

  2012cited by this paper
• Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.

  2011cited by this paper
• Development and Inter-Rater Reliability of the Liverpool Adverse Drug Reaction Causality Assessment Tool

  2011cited by this paper
• This material is the copyright of the original publisher. Unauthorised copying and distribution is prohibited. The Relationship Between Study Characteristics and the Prevalence of Medication-Related Hospitalizations A Literature Review and Novel Analysis

  2010cited by this paper
• The Relationship Between Study Characteristics and the Prevalence of Medication-Related Hospitalizations

  2010cited by this paper
• A protocol for data exploration to avoid common statistical problems

  2010cited by this paper
• Preventability of Drug-Related Harms — Part I

  2010cited by this paper
• Adverse drug reactions as the cause of emergency department admission: focus on the elderly

  2010cited by this paper
• Hospitalizations because of Adverse Drug Reactions in Elderly Patients Admitted through the Emergency Department

  2009cited by this paper
• BMC Clinical Pharmacology BioMed Central

  2009cited by this paper
• The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty

  2009cited by this paper
• New approaches to drug safety: a pharmacovigilance tool kit

  2009cited by this paper
• Adverse-drug-reaction related admissions to a hospital in Scotland

  2008cited by this paper
• Adverse drug reaction‐related hospitalisations: a population‐based cohort study

  2008cited by this paper
• Hospital Admissions Associated with Adverse Drug Reactions: A Systematic Review of Prospective Observational Studies

  2008cited by this paper
• Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece.

  2008cited by this paper
• Prevalence, Clinical Features and Avoidability of Adverse Drug Reactions as Cause of Admission to a Geriatric Unit

  2008cited by this paper
• Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization

  2006cited by this paper
• Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender

  2005cited by this paper
• Adverse drug reactions in Singaporean children.

  2004cited by this paper
• Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

  2004cited by this paper
• Adverse Drug Reactions as Cause of Hospital Admissions: Results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA)

  2002cited by this paper
• Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine.

  2000cited by this paper
• Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot study

  2000cited by this paper
• Adverse drug reactions: definitions, diagnosis, and management.

  2000cited by this paper
• Adverse drug reactions

  1998cited by this paper
• Fortnightly review: Adverse drug reactions

  1998cited by this paper
• Guidelines for ATC classification and DDD assignment

  1996cited by this paper
• Drug related admissions to medical wards: a population based survey.

  1992cited by this paper
• Preventability and severity assessment in reporting adverse drug reactions.

  1992cited by this paper
• Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention

  1990cited by this paper

• Ido1 and Ido2 deficiencies attenuate kainic acid-induced ictogenesis.

  2026cites this paper
• Use of medications with pharmacogenomic guidelines and adverse outcomes in hospitalised older patients: a retrospective cross-sectional study

  2026cites this paper
• Evaluation of Adverse Drug Reactions at Hospital Besut: A 5-year Retrospective Study

  2026cites this paper
• Application of global trigger tool to determine the prevalence of adverse drug reactions in adult patients admitted to general and COVID-19 intensive care units

  2025cites this paper
• A review on adverse drug reaction related to medication in health sector: an account of what we have discovered and implemented—pharmacovigilance

  2025cites this paper
• Targeted adaptive sampling enables clinical pharmacogenomics testing and genome-wide genotyping

  2025cites this paper
• A holistic platform for adverse drug reaction prevention and monitoring: leveraging service-oriented architecture for tailored healthcare solutions

  2025cites this paper
• A feasibility study on implementing pre-emptive pharmacogenomics testing in outpatient clinics in Singapore (IMPT study)

  2025cites this paper
• Real‐World Utilization of Medications With Pharmacogenetic Recommendations in Older Adults: A Scoping Review

  2025cites this paper
• Evaluation of a self-screening tool and patient alert cards to help patients identify and manage severe adverse drug reactions

  2025cites this paper
• Enhancing Clinical Adoption of Pharmacogenomics: Impact of Targeted Training on Healthcare Professionals’ Self-Efficacy and Competency

  2025cites this paper
• A study on drug utilization, evaluation and monitoring of adverse drug reactions in the cardiology department of a tertiary care hospital

  2025cites this paper
• Pharmacists’ Experiences on Adverse Drug Reactions in Saudi Arabia: A Cross-Sectional Study

  2025cites this paper
• A Retrospective Observational Study of Adverse Drug Reactions (ADR) Reported to ADR Monitoring Centre from 2010 to 2020.

  2024cites this paper
• Pharmacogenomics education in China and the United States: advancing personalized medicine.

  2024cites this paper
• Navigating personalized medication: unveiling user needs to forge a cutting-edge platform for proactive prevention and monitoring of adverse drug reactions

  2024influential citation
• Personalized anesthesia and precision medicine: a comprehensive review of genetic factors, artificial intelligence, and patient-specific factors

  2024cites this paper
• Detecting Adverse Drug Reactions through Drug Common Sense Reasoning and Dual-channel Contrastive Learning

  2024influential citation
• A review of real-world evidence on preemptive pharmacogenomic testing for preventing adverse drug reactions: a reality for future health care

  2024influential citation
• Medication review and deprescribing in different healthcare settings: a position statement from an Italian scientific consortium

  2024cites this paper
• Kidney Function Decline and Serious Adverse Drug Reactions in Patients With CKD.

  2023cites this paper
• Incidence and Severity of Adverse Drug Reactions in Medical Intensive Care Unit.

  2023cites this paper
• Adverse drug reactions in the ambulatory internal patients at the emergency department: Focus on causality assessment and drug-drug interactions

  2023cites this paper
• Incidence and patterns of adverse drug reactions among adult patients hospitalized in the University of Gondar comprehensive specialized hospital: A prospective observational follow-up study

  2023cites this paper
• Severity and Management of Adverse Drug Reactions Reported by Patients and Healthcare Professionals: A Cross-Sectional Survey

  2023cites this paper
• Which Adverse Events and Which Drugs Are Implicated in Drug-Related Hospital Admissions? A Systematic Review and Meta-Analysis

  2023cites this paper
• Utilization of Drug Decision Support Strategies Including Drug Characteristics to Reduce the Risk of Iatrogenesis in Advanced Age

  2023cites this paper
• Editorial: Medication safety and interventions to reduce patient harm in low- and middle-income countries

  2023cites this paper
• Development and validation of a pharmacogenomics reporting workflow based on the illumina global screening array chip

  2023cites this paper
• A novel machine learning model based on sparse structure learning with adaptive graph regularization for predicting drug side effects

  2022cites this paper
• Student assistantship programme: an evaluation of impact on readiness to transit from medical student to junior doctor

  2022cites this paper
• Incidence of adverse drug events in patients hospitalized in the medical wards of a teaching referral hospital in Ethiopia: a prospective observational study

  2022cites this paper
• Therapy for feline secondary hypertriglyceridemia with fenofibrate

  2022cites this paper
• Budget impact analysis of a pilot polypharmacy clinic

  2022cites this paper
• Improving prescribing: a feasibility study of pharmacogenetic testing with clinical decision support in primary healthcare in Singapore

  2022cites this paper
• Individual Pharmacotherapy Management (IPM)—IV: Optimized Usage of Approved Antimicrobials Addressing Under-Recognized Adverse Drug Reactions and Drug-Drug Interactions in Polypharmacy

  2022cites this paper
• Pharmacists’ experiences on adverse drug reaction: 10 years later

  2022cites this paper
• Experience of patients with lung cancer and with targeted therapy-related skin adverse drug reactions: A qualitative study

  2022cites this paper
• Pharmacogenomics of Alzheimer's Disease: Novel Strategies for Drug Utilization and Development.

  2022cites this paper
• Ten-year trends in adverse drug reaction–related hospitalizations among people with dementia

  2022cites this paper
• Calycosin Inhibits the Malignant Behaviors of Lung Adenocarcinoma Cells by Regulating the circ_0001946/miR-21/GPD1L/HIF-1α Signaling Axis

  2022cites this paper
• Knowledge and Perception of Pharmacy Practice Students on Causality Assessment of Adverse Drug Reactions

  2021cites this paper
• Modeling the Bioactivation and Subsequent Reactivity of Drugs.

  2021cites this paper
• A Retrospective Descriptive Study of Adverse Drug Reaction Monitoring in Tertiary Care Hospital

  2021cites this paper
• Calycosin Induces Gastric Cancer Cell Apoptosis via the ROS-Mediated MAPK/STAT3/NF-κB Pathway

  2021cites this paper
• Controlling drug release with additive manufacturing-based solutions.

  2021cites this paper
• Validation of a multi-gene qPCR-based pharmacogenomics panel across major ethnic groups in Singapore and Indonesia

  2021cites this paper
• Predictors of Medication-Related Emergency Department Admissions Among Patients with Cardiovascular Diseases at Mbarara Regional Referral Hospital, South-Western Uganda

  2021cites this paper
• Prevalence and Characteristics of Adverse Drug Reaction among Patients in Jubail, Saudi Arabia

  2021cites this paper
• OTT_A_292388 2505..2517

  2021cites this paper
• OAEM_A_309508 279..290

  2021cites this paper
• Drug-related deaths among inpatients: a meta-analysis

  2021cites this paper
• Effects of Adverse Drug Reactions and Adverse Drug Events in Hospital Admission Rates and Re-Hospitalization of Patients

  2021influential citation
• Hospitalizations and deaths related to adverse drug events worldwide: Systematic review of studies with national coverage

  2021cites this paper
• Determinants of Adverse Drug Reactions Due to Tuberculosis Therapy in African Countries: a Systematic Scoping Review Protocol

  2021cites this paper
• Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions

  2021cites this paper
• IT Solutions for Preventing and Monitoring Adverse Drug Reactions: A Systematic Literature Review

  2021influential citation
• Adverse reactions of targeted therapy in cancer patients: a retrospective study of hospital medical data in China

  2020cites this paper
• Effects of the number of drugs used on the prevalence of adverse drug reactions in children

  2020cites this paper
• Pharmacogenomics Implementation Training Improves Self-Efficacy and Competency to Drive Adoption in Clinical Practice

  2020cites this paper
• Adverse Drug Reaction

  2020cites this paper
• 3D-printed Drugs: A Fabrication of Pharmaceuticals towards Personalized Medicine

  2020cites this paper
• Prospective cohort study on adverse drug reactions on all admissions to internal medicine: Incidence, risk factors and fatality

  2020cites this paper
• Fenofibrate treatment for severe hypertriglyceridemia in dogs.

  2020cites this paper
• Cohort study on adverse drug reactions in adults admitted to the medical wards of a tertiary hospital in Nigeria: Prevalence, incidence, risk factors and fatality

  2020cites this paper
• Adverse Drug Reactions in Patients with CKD.

  2020cites this paper
• Prescription patterns of outpatients and the potential of multiplexed pharmacogenomic testing

  2020cites this paper
• Protocol for a randomised controlled trial evaluating the impact of a community pharmacy discharge medication reconciliation service on unplanned hospital readmissions - The DCMedsRec trial.

  2020cites this paper
• Clinical usefulness of genetic testing for drug toxicity in cancer care: decision-makers’ framing, knowledge and perceptions

  2020cites this paper
• Adverse Drug Reactions in Selected Wards of the Yangon General Hospital and Yangon Specialty Hospital During the First Quarter of 2019: An Active Pharmacovigilance Study in Myanmar

  2020cites this paper
• The characteristics and regularities of cardiac adverse drug reactions induced by Chinese materia medica: A bibliometric research and association rules analysis.

  2020cites this paper
• Veilig voorschrijven bij levercirrose

  2019cites this paper
• Pharmacogenetic biomarkers for chemotherapy-induced adverse drug reactions

  2019cites this paper
• Analysis of spontaneous individual case safety reports reported at adverse drug reaction monitoring centre: tertiary care teaching hospital in South India

  2019cites this paper
• Adverse drug reactions monitoring of anticoagulant drugs used in cardiac coronary care unit of a tertiary care hospital

  2019cites this paper
• Development of a mortality score to assess risk of adverse drug reactions among hospitalized patients with moderate to severe chronic kidney disease

  2019cites this paper
• Hospitalización por reacciones adversas a medicamentos

  2019cites this paper
• Detecting adverse drug reactions in discharge summaries of electronic medical records using Readpeer

  2019cites this paper
• Implementation and obstacles of pharmacogenetics in clinical practice: An international survey

  2019cites this paper
• Herbal Pharmacovigilance : Are Ghanaian Herbal Medicine Practitioners Equipped Enough to Assist in Monitoring the Safety of Herbal Medicines ?-A Survey in Tamale , Ghana

  2019cites this paper
• Preventable ADRs leading to hospitalization — results of a long-term prospective safety study with 6,427 ADR cases focusing on elderly patients

  2018cites this paper
• LC–MS/MS assay for assessing medical adherence in patients under warfarin maintenance therapy

  2018cites this paper
• Comparative Analysis of Ethical-the-counter Drugs and Over-the-counter Drugs for the Adverse Events from the Community Pharmacy

  2018cites this paper
• Distinguishing adverse drug reactions, the noxious effects of medicines at a tertiary care hospital

  2018cites this paper
• A retrospective analysis of adverse drug reactions reported at a tertiary care hospital in South India

  2018influential citation
• Which drugs cause treatment-related problems? Analysis of 10,672 problems within the outpatient setting

  2018cites this paper
• Benefits and risks of the treatment with fibrates––a comprehensive summary

  2018cites this paper
• Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults

  2018influential citation
• Which drugs cause treatment-related problems? analysis of 10,672 problems within the outpatient setting

  2018cites this paper
• Which drugs cause treatment-related problems? analysis of 10,672 problems within the outpatient setting

  2018cites this paper
• RMN haut champ et bas champ pour l'analyse de produits de santé

  2018cites this paper
• Mortality among patients due to adverse drug reactions that lead to hospitalization: a meta-analysis

  2018cites this paper
• Role of Medicines of Unknown Identity in Adverse Drug Reaction-Related Hospitalizations in Developing Countries: Evidence from a Cross-Sectional Study in a Teaching Hospital in the Lao People’s Democratic Republic

  2017cites this paper
• Early rehospitalizations of frail elderly patients – the role of medications: a clinical, prospective, observational trial

  2017cites this paper
• HLA-associated drug hypersensitivity and the prediction of adverse drug reactions.

  2017cites this paper
• Adverse drug reactions in the department of dermatology at a tertiary care hospital: a prospective study

  2017influential citation
• Pharmacist-initiated deprescribing in hospitalised elderly: prevalence and acceptance by physicians

  2017cites this paper
• Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational study

  2016cites this paper
• Disturbance of consciousness induced by isotretinoin and azithromycin: A case

  year unknowncites this paper
• Use of a Self-Screening Tool and Patient Alert Cards to Help Patients Identify and Manage Severe Adverse Drug Reactions

  year unknowncites this paper